Incannex Healthcare Files S-1/A Amendment

Ticker: IXHL · Form: S-1/A · Filed: Jul 17, 2024 · CIK: 1873875

Incannex Healthcare Inc. S-1/A Filing Summary
FieldDetail
CompanyIncannex Healthcare Inc. (IXHL)
Form TypeS-1/A
Filed DateJul 17, 2024
Risk Levelmedium
Pages15
Reading Time18 min
Key Dollar Amounts$2, $0, $0.001, $2.76, $1.235 billion
Sentimentneutral

Sentiment: neutral

Topics: sec-filing, registration, pharmaceuticals

TL;DR

INCX S-1/A filed - looks like they're still prepping for something big.

AI Summary

Incannex Healthcare Inc. filed an S-1/A amendment on July 17, 2024, for its registration statement. The company, previously known as Incannex Healthcare Ltd, is incorporated in Delaware and operates in the pharmaceutical preparations sector (SIC 2834). Its principal executive offices are located in Norwest, NSW, Australia.

Why It Matters

This filing indicates Incannex Healthcare Inc. is moving forward with its registration process, which is a necessary step for public offerings or other securities-related actions.

Risk Assessment

Risk Level: medium — S-1/A filings are often precursors to significant corporate events like IPOs or secondary offerings, which carry inherent market risks.

Key Numbers

  • 2834 — SIC Code (Pharmaceutical Preparations industry)
  • 333-280670 — SEC File Number (Registration Number)

Key Players & Entities

  • Incannex Healthcare Inc. (company) — Registrant
  • 20240717 (date) — Filing Date
  • 333-280670 (registration_number) — SEC File Number
  • Incannex Healthcare Ltd (company) — Former Company Name
  • George Anastassov (person) — Director

FAQ

What is the purpose of this S-1/A filing?

This is an amendment to a previously filed Form S-1 registration statement, indicating updates or changes to the initial filing.

When was this amendment filed?

The amendment was filed on July 17, 2024.

What is Incannex Healthcare Inc.'s former name?

The company's former name was Incannex Healthcare Ltd, with a name change date of July 20, 2021.

Where are Incannex Healthcare Inc.'s principal executive offices located?

The principal executive offices are located at Suite 105, 8 Century Circuit Norwest, NSW 2153 Australia.

What is the Standard Industrial Classification (SIC) code for Incannex Healthcare Inc.?

The SIC code is 2834, which corresponds to Pharmaceutical Preparations.

Filing Stats: 4,494 words · 18 min read · ~15 pages · Grade level 16.7 · Accepted 2024-07-17 08:47:25

Key Financial Figures

  • $2 — tock and accompanying common warrant of $2.76, the last reported sale price of our
  • $0 — d to the public in this offering, minus $0.001, and the exercise price of each pre
  • $0.001 — rice of each pre-funded warrant will be $0.001 per share. The pre-funded warrants will
  • $2.76 — price of our common stock on Nasdaq was $2.76 per share of common stock. The public o
  • $1.235 billion — e Act, our annual gross revenues exceed $1.235 billion or we issue more than $1.0 billion of n
  • $1.0 billion — ed $1.235 billion or we issue more than $1.0 billion of non-convertible debt in any three-ye
  • $250.0 million — ock held by non-affiliates is less than $250.0 million measured on the last business day of ou
  • $100.0 million — ter, or our annual revenue is less than $100.0 million during the most recently completed fisc
  • $700.0 million — ock held by non-affiliates is less than $700.0 million measured on the last business day of ou

Filing Documents

Use of Proceeds

Use of Proceeds 30 Dividend Policy 30 Capitalization 31

Management's Discussion and Analysis of Financial Condition and Results of Operations

Management's Discussion and Analysis of Financial Condition and Results of Operations 33

Business

Business 42 Management 98 Executive and Director Compensation 103 Certain Relationships and Related Party Transactions 111 Principal Stockholders 112

Description of Capital Stock

Description of Capital Stock 113

Description of Securities We Are Offering

Description of Securities We Are Offering 116 Material United States Federal Income Tax Consequences 120 Plan of Distribution 126 Legal Matters 128 Experts 128 Where You Can Find More Information 128 You should rely only on the information contained in this prospectus and any related free-writing prospectus that we authorize to be distributed to you. We have not authorized any person to provide you with information different from that contained in this prospectus or any related free-writing prospectus that we authorize to be distributed to you. This prospectus is not an offer to sell, nor is it seeking an offer to buy, these securities in any state where the offer or sale is not permitted. The information in this prospectus speaks only as of the date of this prospectus unless the information specifically indicates that another date applies, regardless of the time of delivery of this prospectus. No action is being taken in any jurisdiction outside the United States to permit a public offering of the securities or possession or distribution of this prospectus in that jurisdiction. Persons who come into possession of this prospectus in jurisdictions outside the United States are required to inform themselves about and to observe any restrictions as to this offering and the distribution of the prospectus applicable to that jurisdiction. i Trademarks We own or have rights to trademarks and trade names that we use in connection with the operation of our business, including our corporate name, logos, product names and website names. Solely for your convenience, some of the trademarks and trade names referred to in this prospectus are listed without the and TM symbols, but we will assert, to the fullest extent under applicable law, our rights to our trademarks and trade names. S tatistical and O ther I ndustry and M arket D ata This prospectus includes statistical and other industry and market data and contains estimates and information c

View Full Filing

View this S-1/A filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.